rs6497676

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001134407.3(GRIN2A):​c.414+93632C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.588 in 151,740 control chromosomes in the GnomAD database, including 26,951 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.59 ( 26951 hom., cov: 30)

Consequence

GRIN2A
NM_001134407.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.03

Publications

9 publications found
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GRIN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Landau-Kleffner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • continuous spikes and waves during sleep
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2ANM_001134407.3 linkc.414+93632C>T intron_variant Intron 2 of 12 ENST00000330684.4 NP_001127879.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2AENST00000330684.4 linkc.414+93632C>T intron_variant Intron 2 of 12 1 NM_001134407.3 ENSP00000332549.3

Frequencies

GnomAD3 genomes
AF:
0.588
AC:
89162
AN:
151620
Hom.:
26932
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.443
Gnomad AMI
AF:
0.632
Gnomad AMR
AF:
0.696
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.561
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.678
Gnomad MID
AF:
0.633
Gnomad NFE
AF:
0.636
Gnomad OTH
AF:
0.605
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.588
AC:
89234
AN:
151740
Hom.:
26951
Cov.:
30
AF XY:
0.592
AC XY:
43870
AN XY:
74138
show subpopulations
African (AFR)
AF:
0.443
AC:
18305
AN:
41332
American (AMR)
AF:
0.696
AC:
10616
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2224
AN:
3470
East Asian (EAS)
AF:
0.562
AC:
2886
AN:
5136
South Asian (SAS)
AF:
0.586
AC:
2812
AN:
4798
European-Finnish (FIN)
AF:
0.678
AC:
7136
AN:
10530
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.636
AC:
43218
AN:
67918
Other (OTH)
AF:
0.605
AC:
1275
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1778
3557
5335
7114
8892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
744
1488
2232
2976
3720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.616
Hom.:
17696
Bravo
AF:
0.584
Asia WGS
AF:
0.561
AC:
1953
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.10
DANN
Benign
0.19
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6497676; hg19: chr16-10180223; API